Biological drug leaders meet ­
Korea JoongAng Daily

Home > Business > Industry

print dictionary print
Published: 27 Jun. 2016, 21:19

Biological drug leaders meet ­

테스트

From left, Tom Pike, CEO of Quintiles, a biopharmaceutical contract research organization; Julie Gerberding, executive vice president of MSD and former director of the U.S. Centers for Disease Control; Brian H. Gu, co-head of JP Morgan Chase & Co.’s Asia Pacific M&A, TMT and Healthcare; and Sohn Yeo-won, National Institute of Food and Drug Safety Evaluation.

The group held a press conference Monday at the Global Bio Conference at Seoul’s COEX exhibition center in southern Seoul. About 2,000 officials from the biopharmaceutical industry, including Celltrion CEO Kim Hyoung-ki, as well as scholars and government officials are attending the forum that ends Friday. [NEWSIS]




tags

More in Industry

Lotte Group sells China theme park project to local Chinese company

LG Display's Q1 operating loss of $341.1 million better than estimates

Posco reports 25% drop in net profit for Q1 at $435.9 million

HYBE pushed NewJeans aside for Le Sserafim, says Min Hee-jin

LG Electronics operating profit drops 10.8% on year in first quarter

Related Stories

Yang Hyun-jun makes first Scottish Cup start as Celtic beat Aberdeen 6-5 on penalties in electric semifinal

Korea ends Covid-19 response, disbands disaster management headquarters

Stoke's Bae Jun-ho gets assist in 3-0 win over Plymouth with two games to go

HD Korea Shipbuilding to support carbon neutrality for subcontractors

Former No. 1 Ryu So-yeon retires as three Korean golfers make major top 10
Log in to Twitter or Facebook account to connect
with the Korea JoongAng Daily
help-image Social comment?
s
lock icon

To write comments, please log in to one of the accounts.

Standards Board Policy (0/250자)